We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$2.25B
AUM Growth
+$405M
Cap. Flow
+$2.31B
Cap. Flow %
102.69%
Top 10 Hldgs %
14.53%
Holding
1,145
New
406
Increased
187
Reduced
178
Closed
367

Sector Composition

Rank Sector Weight
1 Healthcare 22.31%
2 Consumer Discretionary 16.07%
3 Industrials 13.87%
4 Technology 11.32%
5 Financials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POLY
326
DELISTED
Plantronics, Inc.
POLY
$1.65M 0.07%
+27,300
New +$1.87M
BMRN icon
327
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.64M 0.07%
16,900
-68,900
-80% -$6.88M
PEP icon
328
PepsiCo
PEP
$190B
$1.63M 0.07%
+14,600
New +$1.65M
ODFL icon
329
Old Dominion Freight Line
ODFL
$44.1B
$1.63M 0.07%
+30,300
New +$1.53M
GRMN
330
Garmin
GRMN
$56.7B
$1.63M 0.07%
+23,200
New +$1.52M
T icon
331
AT&T
T
$159B
$1.63M 0.07%
+64,074
New +$1.57M
ASMB icon
332
Assembly Biosciences
ASMB
$498M
$1.62M 0.07%
3,633
-200
-5% -$93.7K
AVY icon
333
Avery Dennison
AVY
$13B
$1.62M 0.07%
+14,913
New +$1.6M
SBNY
334
DELISTED
Signature Bank
SBNY
$1.6M 0.07%
13,900
+749
+6% +$88.2K
AMRN
335
Amarin Corp
AMRN
$299M
$1.57M 0.07%
+4,820
New +$364K
FITB
336
Fifth Third Bancorp
FITB
$51.2B
$1.57M 0.07%
56,100
-30,455
-35% -$894K
CELG
337
DELISTED
Celgene Corp
CELG
$1.56M 0.07%
17,400
-66,240
-79% -$5.85M
IDXG
338
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$1.54M 0.07%
100,000
+77,500
+344% +$934K
FIS icon
339
Fidelity National Information Services
FIS
$23.1B
$1.54M 0.07%
14,100
+11,736
+496% +$1.26M
PTLA
340
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.54M 0.07%
57,700
+32,600
+130% +$1.06M
TRN icon
341
Trinity Industries
TRN
$2.49B
$1.52M 0.07%
+57,505
New +$1.51M
BLK icon
342
Blackrock
BLK
$169B
$1.51M 0.07%
+3,200
New +$1.56M
EXAS
343
DELISTED
Exact Sciences
EXAS
$1.51M 0.07%
+19,100
New +$1.25M
CDLX icon
344
Cardlytics
CDLX
$21.7M
$1.5M 0.07%
+5,990
New +$1.29M
D icon
345
Dominion Energy
D
$60.8B
$1.5M 0.07%
+21,300
New +$1.51M
PEN icon
346
Penumbra
PEN
$12.7B
$1.5M 0.07%
10,000
+4,151
+71% +$581K
AGNC icon
347
AGNC Investment
AGNC
$12.4B
$1.49M 0.07%
79,800
+64,500
+422% +$1.23M
BRC icon
348
Brady Corp
BRC
$4.44B
$1.48M 0.07%
33,900
-7,300
-18% -$290K
GPC icon
349
Genuine Parts
GPC
$17.1B
$1.48M 0.07%
+14,900
New +$1.46M
ROP icon
350
Roper Technologies
ROP
$38.8B
$1.48M 0.07%
+5,000
New +$1.47M

Similar funds

Schonfeld Strategic Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Schonfeld Strategic Advisors held 1,145 positions worth $2.25B, up 22% from $1.84B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Schonfeld Strategic Advisors deployed $2.31B of net new capital in Q3 2018, opening 406 new positions and adding to 187 existing holdings. Its largest new stake was Fortive: 632,433 shares worth $33.6M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Equitable Holdings, an estimated $22.7M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2018 buy was Fortive: 632,433 shares worth $33.6M.
  • Schonfeld Strategic Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $93.2M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2018 reduction was Equitable Holdings, cutting an estimated $22.7M.
  • Schonfeld Strategic Advisors fully exited Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00 in Q3 2018, selling an estimated $22.4M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 15% of its $2.25B portfolio in Q3 2018.
  • Schonfeld Strategic Advisors opened 406 new positions and closed 367 in Q3 2018.
  • Schonfeld Strategic Advisors's portfolio value rose 22% quarter-over-quarter to $2.25B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.